42 |
2021 |
Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma. |
Scientific Reports |
바로가기
|
41 |
2021 |
Genomic Analysis of Korean Patient With Microcephaly. |
Frontiers in Genetics |
바로가기
|
40 |
2020 |
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient |
Genome Medicine |
바로가기
|
39 |
2020 |
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma |
Nature Communications |
바로가기
|
38 |
2020 |
Plasma Cell-Free DNA Is a Prognostic Biomarker for Survival in Patients With Aggressive non-Hodgkin Lymphomas. |
Annals of Hematology |
바로가기
|
37 |
2020 |
Lineage-dependent Gene Expression Programs Influence the Immune Landscape of Colorectal Cancer |
Nature Genetics |
바로가기
|
36 |
2020 |
Junction Location Identifier (JuLI): Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology |
Journal of Molecular Diagnostics |
바로가기
|
35 |
2020 |
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. |
Annals Oncology |
바로가기
|
34 |
2020 |
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion. |
Clinical cancer research |
바로가기
|
33 |
2019 |
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial |
Cancer Discovery |
바로가기
|